Filip Krag Knop

Filip Krag Knop

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


Publication year:
All
76 - 100 out of 548Page size: 25
Sort by: 1st author
  1. Published

    Gluco-Metabolic Effects of Pharmacotherapy-Induced Modulation of Bile Acid Physiology

    Bronden, A. & Knop, Filip Krag, 2020, In: Journal of Clinical Endocrinology & Metabolism. 105, 1, p. 362-373

    Research output: Contribution to journal › Review › Research › peer-review

  2. Published

    Sevelamer in a diabetologist's perspective: A phosphate-binding resin with glucose-lowering potential

    Brønden, Andreas, Hansen, M., Sonne, David Peick, Rohde, U., Vilsbøll, Tina & Knop, Filip Krag, 1 Feb 2015, In: Diabetes, Obesity and Metabolism. 17, 2, p. 116-120 5 p.

    Research output: Contribution to journal › Review › Research › peer-review

  3. Published

    Sevelamer in a diabetologist's perspective: A phosphate-binding resin with glucose-lowering potential

    Brønden, Andreas, Hansen, M., Sonne, David Peick, Rohde, U., Vilsbøll, Tina & Knop, Filip Krag, 1 Feb 2015, In: Diabetes, Obesity and Metabolism. 17, 2, p. 116-120 5 p.

    Research output: Contribution to journal › Review › Research › peer-review

  4. Published

    Clinical Pharmacokinetics and Pharmacodynamics of Albiglutide

    Brønden, A., Knop, Filip Krag & Christensen, Mikkel Bring, 2017, In: Clinical Pharmacokinetics. 56, 7, p. 719-731

    Research output: Contribution to journal › Review › Research › peer-review

  5. Published

    Glucose-lowering effects and mechanisms of the bile acid-sequestering resin sevelamer

    Brønden, A., Mikkelsen, K., Sonne, D. P., Hansen, M., Våben, C., Gabe, M. N., Rosenkilde, Mette, Tremaroli, V., Wu, H., Bäckhed, F., Rehfeld, Jens Frederik, Holst, Jens Juul, Vilsbøll, Tina & Knop, Filip Krag, Jul 2018, In: Diabetes, Obesity and Metabolism. 20, 7, p. 1623-1631

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Single-Dose Metformin Enhances Bile Acid-Induced Glucagon-Like Peptide-1 Secretion in Patients With Type 2 Diabetes

    Brønden, A., Albér, A., Rohde, U., Rehfeld, Jens Frederik, Holst, Jens Juul, Vilsbøll, Tina & Knop, Filip Krag, Nov 2017, In: The Journal of clinical endocrinology and metabolism. 102, 11, p. 4153-4162 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    The bile acid-sequestering resin sevelamer eliminates the acute GLP-1 stimulatory effect of endogenously released bile acids in patients with type 2 diabetes

    Brønden, A., Albér, A., Rohde, U., Gasbjerg, Lærke Smidt, Rehfeld, Jens Frederik, Holst, Jens Juul, Vilsbøll, Tina & Knop, Filip Krag, 1 Feb 2018, In: Diabetes, Obesity and Metabolism. 20, 2, p. 362-369

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Albiglutide for treating type 2 diabetes: an evaluation of pharmacokinetics/pharmacodynamics and clinical efficacy

    Brønden, A., Naver, S. V., Knop, Filip Krag & Christensen, M., 2015, In: Expert Opinion on Drug Metabolism & Toxicology. 11, 9, p. 1493-1503 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Changes in oxidative nucleic acid modifications and inflammation following one-week treatment with the bile acid sequestrant sevelamer: Two randomised, placebo-controlled trials

    Brønden, A., Larsen, E. L., Karstoft, K., Henriksen, T., Vilsbøll, Tina, Poulsen, Henrik Enghusen & Knop, Filip Krag, Feb 2020, In: Journal of Diabetes and its Complications. 34, 2, 8 p., 107446.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Prototype of an evidence-based tool to aid individualized treatment for type 2 diabetes

    Buse, J. B., Holst, I., Knop, Filip Krag, Kvist, K., Thielke, D. & Pratley, R., 2021, In: Diabetes, Obesity and Metabolism. 23, 7, p. 1666-1671

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies

    Calanna, S., Christensen, M., Holst, Jens Juul, Laferrère, B., Gluud, Lise Lotte, Vilsbøll, Tina & Knop, Filip Krag, May 2013, In: Diabetologia. 56, 5, p. 965-72 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    Lipid and liver abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes

    Calanna, S., Scicali, R., Di Pino, A., Knop, Filip Krag, Piro, S., Rabuazzo, A. M. & Purrello, F., Jun 2014, In: Nutrition, Metabolism and Cardiovascular Diseases. 24, 6, p. 670-676 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  13. Published

    Alpha- and beta-cell abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes

    Calanna, S., Scicali, R., Di Pino, A., Knop, Filip Krag, Piro, S., Rabuazzo, A. M. & Purrello, F., 2014, In: Acta Diabetologica. 51, 4, p. 567-575

    Research output: Contribution to journal › Journal article › Research › peer-review

  14. Published

    Secretion of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes: systematic review and meta-analysis of clinical studies

    Calanna, S., Christensen, Mikkel Bring, Holst, Jens Juul, Laferrère, B., Gluud, Lise Lotte, Vilsbøll, T. & Knop, Filip Krag, Oct 2013, In: Diabetes Care. 36, 10, p. 3346-52 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  15. Published

    Adverse drug reactions associated with the use of liraglutide in patients with type 2 diabetes-focus on pancreatitis and pancreas cancer

    Chalmer, T., Almdal, Thomas Peter, Vilsbøll, Tina & Knop, Filip Krag, 2015, In: Expert Opinion on Drug Safety. 14, 1, p. 171-180

    Research output: Contribution to journal › Review › Research › peer-review

  16. Published

    Efficacy and Safety of Glimepiride With or Without Linagliptin Treatment in Patients With HNF1A Diabetes (Maturity-Onset Diabetes of the Young Type 3): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial (GLIMLINA)

    Christensen, A. S., Haedersdal, S., Stoy, J., Storgaard, H., Kampmann, U., Forman, Julie Lyng, Seghieri, M., Holst, Jens Juul, Hansen, Torben, Knop, Filip Krag & Vilsbøll, Tina, 2020, In: Diabetes Care. 43, 9, p. 2025-2033 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  17. Published

    GIP and GLP-1 Potentiate Sulfonylurea-Induced Insulin Secretion in HNF1A Diabetes

    Christensen, A. S., Haedersdal, S., Storgaard, H., Rose, K., Hansen, N. L., Holst, Jens Juul, Hansen, Torben, Knop, Filip Krag & Vilsbøll, Tina, 2019, In: Diabetes. 68, Suppl. 1, 1 p., 981-P.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  18. Published

    GIP and GLP-1 Potentiate Sulfonylurea-Induced Insulin Secretion in Hepatocyte Nuclear Factor 1 alpha Mutation Carriers

    Christensen, A. S., Haedersdal, S., Storgaard, H., Rose, K., Hansen, N. L., Holst, Jens Juul, Hansen, Torben, Knop, Filip Krag & Vilsbøll, Tina, 2020, In: Diabetes. 69, 9, p. 1989-2002 14 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  19. Published

    Glimepiride monotherapy versus combination of glimepiride and linagliptin therapy in patients with HNF1A-diabetes: a protocol for a randomised, double-blinded, placebo-controlled trial

    Christensen, A. S., Storgaard, H., Hædersdal, S., Hansen, Torben, Knop, Filip Krag & Vilsbøll, Tina, 2018, In: BMJ Open. 8, p. 1-9 e022517.

    Research output: Contribution to journal › Journal article › Research › peer-review

  20. Published

    Transfer of liraglutide from blood to cerebrospinal fluid is minimal in patients with type 2 diabetes

    Christensen, M., wbf943, wbf943, Hartmann, Bolette, Grevstad, U., Rosenkilde, Mette, Holst, Jens Juul, Vilsbøll, T. & Knop, Filip Krag, Nov 2015, In: International journal of obesity (2005). 39, 11, p. 1651-1654 4 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  21. Published

    The design and discovery of lixisenatide for the treatment of type 2 diabetes mellitus

    Christensen, M., Miossec, P., Larsen, B. D., Werner, U. & Knop, Filip Krag, 2014, In: Expert Opinion on Drug Discovery. 9, 10, p. 1223-1251 29 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  22. Published

    Once-weekly GLP-1 agonists: How do they differ from exenatide and liraglutide?

    Christensen, M. & Knop, Filip Krag, 1 Apr 2010, In: Current Diabetes Reports. 10, 2, p. 124-32 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  23. Published

    Effects of glucose-dependent insulinotropic polypeptide on glucagon

    Christensen, M. & Knop, Filip Krag, Sep 2016, In: Cardiovascular Endocrinology. 5, 3, p. 75-81 7 p.

    Research output: Contribution to journal › Review › Research › peer-review

  24. Published

    Lixisenatide, a novel GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus

    Christensen, M., Knop, Filip Krag, Holst, Jens Juul & Vilsboll, T., 2009, In: IDrugs. The Investigational Drugs Journal. 12, 8, p. 503-13 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  25. Published

    The alpha-cell as target for type 2 diabetes therapy

    Christensen, M., Bagger, J. I., Vilsbøll, Tina & Knop, Filip Krag, 2011, In: Review of Diabetic Studies. 8, 3, p. 369-81 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...22 Next

ID: 40100368